Home > Category > Biochemical Reagent > Regular Reagent > N-Acetylneuraminic Acid, tetramer(α,2→8) 〔DP4〕

N-Acetylneuraminic Acid, tetramer(α,2→8) 〔DP4〕

Nacalai Tesque95%(HPLC)

Catalog No：00642-42 CAS No.： MDLNo： Brand:Nacalai Tesque purity：95%(HPLC) 特性： Purpose:for research of sugar chain SP

Share

Size	Availability	Price(USD)
25MG	现货或2周左右	$44442.00

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	N-Acetylneuraminic Acid, tetramer(α,2→8) 〔DP4〕
Storage condition	冷冻

Related literature

Sorry, there is no relevant literature

Related

0.1mol/l-Zinc Sulfate Solution

0.1mol/l-Zinc Sulfate Solution

Lead Standard Solution

Lead Standard Solution

Zinc Standard Solution

Zinc Standard Solution

Antimony Standard Solution

Antimony Standard Solution

0.5mol/l-Potassium Hydroxide Solution(Ethanol Solution)

0.5mol/l-Potassium Hydroxide Solution(Ethanol Solution)

0.1mol/l-Zinc Solution

0.1mol/l-Zinc Solution

0.1mol/l-Potassium Hydroxide Solution(Ethanol Solution)

0.1mol/l-Potassium Hydroxide Solution(Ethanol Solution)

0.01mol/l-Silver Nitrate Solution

0.01mol/l-Silver Nitrate Solution

0.5mol/l-Iodine Solution

0.5mol/l-Iodine Solution

0.02mol/l-Silver Nitrate Solution

0.02mol/l-Silver Nitrate Solution

History

N-Acetylneuraminic Acid, tetramer(α,2→8) 〔DP4〕

N-Acetylneuraminic Acid, tetramer(α,2→8) 〔DP4〕

N-Acetylneuraminic Acid, hexamer(α,2→8) 〔DP6〕

N-Acetylneuraminic Acid, hexamer(α,2→8) 〔DP6〕

Luteinizing Hormone Releasing Hormone (LH-RH), human

Luteinizing Hormone Releasing Hormone (LH-RH), human

Norethindrone

Stevioside (hydrate)

Stevioside (hydrate)

(11bS)-2,6-Bis[4-(2-naphthalenyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bS)-2,6-Bis[4-(2-naphthalenyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

NA ≥98%,99%e.e.

(11bS)-2,6-Bis(4-chlorophenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bS)-2,6-Bis(4-chlorophenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

NA ≥98%,99%e.e.

(11bR)-2,6-Bis[4-(2-naphthalenyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bR)-2,6-Bis[4-(2-naphthalenyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

NA ≥98%,99%e.e.

(11bR)-2,6-Bis(4-chlorophenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bR)-2,6-Bis(4-chlorophenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

915038-16-3 ≥98%,99%e.e.

(11bS)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bS)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

NA ≥98%,99%e.e.